HB 1569 Summary

• Requires healthcare insurers to count third-party cost-sharing assistance (payments made on behalf of enrollees) toward an enrollee's deductibles, copayments, coinsurance, and other cost-sharing requirements when calculating what patients owe.

• Applies to health benefit plans entered into, amended, extended, or renewed on or after January 1, 2022, with an exception delaying the Evidenced-Based Prescription Drug Program until January 1, 2024.

• Excludes from the requirement name-brand prescription drugs that are not medically necessary when a medically appropriate generic equivalent exists.

• Requires the Evidenced-Based Prescription Drug Program to submit quarterly reports to the Insurance Commissioner, Arkansas Legislative Audit, and Legislative Council detailing enrollee savings, manufacturer rebates received, and how rebates were applied.

• Directs the Insurance Commissioner to promulgate rules necessary to implement the act, with final rules to be filed by January 1, 2022.